COVID-19: European Medicines Agency human medicines committee (CHMP) recommends authorisation of monoclonal antibody sotrovimab (Xevudy), EMA (published 16th December 2021)

The Committee recommended authorising sotrovimab for treating COVID-19 in adults and adolescents (from 12 years of age and weighing at least 40 kilograms) who do not require supplemental oxygen and who are at increased risk of the disease becoming severe.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news